Financhill
Sell
38

VKTX Quote, Financials, Valuation and Earnings

Last price:
$29.00
Seasonality move :
8.5%
Day range:
$30.18 - $34.38
52-week range:
$18.92 - $43.15
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
5.39x
Volume:
8.6M
Avg. volume:
3.6M
1-year change:
3.99%
Market cap:
$3.4B
Revenue:
--
EPS (TTM):
-$3.18

Earnings Data

Next earnings date for VKTX
Apr 29
2026
Most recent earnings per share
-$0.81
Missed by $0.13
(Oct 22/2025)
Consensus Estimate
-$0.67
(Oct 22/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

VKTX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
04/29/2026 Q1 -- -- -- -$0.94 --
02/11/2026 Q4 -- -- -- -$0.90 --
10/22/2025 Q3 -- -- -$0.81 -$0.67 -$0.13
07/23/2025 Q2 -- -- -$0.58 -$0.44 -$0.14
04/23/2025 Q1 -- -- -$0.41 -$0.31 -$0.10
02/05/2025 Q4 -- -- -$0.32 -$0.27 -$0.05
10/23/2024 Q3 -- -- -$0.22 -$0.24 $0.01
07/24/2024 Q2 -- -- -$0.20 -$0.27 $0.07
04/24/2024 Q1 -- -- -$0.26 -$0.28 $0.01
02/07/2024 Q4 -- -- -$0.25 -$0.25 -$0.00
10/25/2023 Q3 -- -- -$0.23 -- --
07/26/2023 Q2 -- -- -$0.19 -- --
04/26/2023 Q1 -- -- -$0.25 -- --
02/08/2023 Q4 -- -- -$0.26 -- --
10/26/2022 Q3 -- -- -$0.21 -- --
07/27/2022 Q2 -- -- -$0.23 -- --
04/27/2022 Q1 -- -- -$0.21 -- --
02/09/2022 Q4 -- -- -$0.16 -- --
11/03/2021 Q3 -- -- -$0.17 -- --
07/28/2021 Q2 -- -- -$0.20 -- --
04/28/2021 Q1 -- -- -$0.19 -- --
02/17/2021 Q4 -- -- -$0.15 -- --
10/28/2020 Q3 -- -- -$0.13 -- --
07/29/2020 Q2 -- -- -$0.13 -- --
04/30/2020 Q1 -- -- -$0.13 -- --
02/26/2020 Q4 -- -- -$0.10 -- --
11/05/2019 Q3 -- -- -$0.08 -- --
08/01/2019 Q2 -- -- -$0.11 -- --
05/02/2019 Q1 -- -- -$0.07 -- --
03/13/2019 Q4 -- -- -$0.07 -- --
11/07/2018 Q3 -- -- -$0.11 -- --
08/09/2018 Q2 -- -- -$0.13 -- --
05/09/2018 Q1 -- -- -$0.10 -- --
03/07/2018 Q4 -- -- -$0.14 -- --
11/08/2017 Q3 -- -- -$0.22 -- --
08/09/2017 Q2 -- -- -$0.21 -- --
03/31/2017 Q1 -- -- -$0.23 -- --
12/31/2016 Q4 -- -- -$0.18 -- --
09/30/2016 Q3 -- -- -$0.20 -- --
06/30/2016 Q2 -- -- -$0.22 -- --
03/31/2016 Q1 -- -- -$0.40 -- --

Viking Therapeutics, Inc. Earnings Questions

  • How Much did Viking Therapeutics, Inc. Generate in Revenue Last Quarter?

    Viking Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Viking Therapeutics, Inc. Beat Earnings Last Quarter?

    Viking Therapeutics, Inc. announced earnings per share of -$0.81 which represents a miss of analyst forecast a -$0.67 per share.

  • Is Viking Therapeutics, Inc. Profitable?

    Viking Therapeutics, Inc. reported -$94K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Viking Therapeutics, Inc. EPS Next Year?

    Viking Therapeutics, Inc.'s earnings are forecast to decrease from -$3.19 per share to -$2.61 per share next year representing a decrease of -30.4%.

  • When is Viking Therapeutics, Inc.'s Earnings Date?

    Viking Therapeutics, Inc.'s next earnings date is April 29, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will UnitedHealth Stock Recover?
Will UnitedHealth Stock Recover?

Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…

Is Lumentum The Best Laser Stock to Buy?
Is Lumentum The Best Laser Stock to Buy?

Though certainly less well-known than the huge tech businesses that…

Is Planet Fitness Stock Undervalued?
Is Planet Fitness Stock Undervalued?

Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 64x

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 35x

Sell
42
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 29x

Alerts

Sell
17
ICLR alert for Feb 13

ICON plc [ICLR] is up 15.9% over the past day.

Buy
67
CGNX alert for Feb 13

Cognex Corp. [CGNX] is up 0.31% over the past day.

Buy
77
IPGP alert for Feb 13

IPG Photonics Corp. [IPGP] is up 2.47% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock